Long Term Outcomes of Relapsed/Refractory Non-Hodgkin Lymphoma:
A Single Center Experience

Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma

The Clinical Characteristics and Treatment Response of Patients with Low Grade Non-Hodgkin Lymphoma

Liposomal Doxorubicin based Chemotherapy in the treatment of Relapsed Diffuse Large B-cell Lymphoma

Third line Treatment in Relapsed/Refractory Hodgkin's Lymphoma and Aggressive non-Hodgkin Lymphoma after 2nd line ESHAP or GEMOX

Outcome of Second Line Chemotherapy (Gemcitabine, Dexamethasone, and Cisplatin) in Relapsed and Refractory Non Hodgkin Lymphoma

Treatment Outcome and Prognostic Factors in Children and Adolescents with Relapsed and Refractory Classic Hodgkin Lymphoma...

Early Complete Response after Chemotherapy as A Prognostic Indicator for Final Outcome in High Grade Non-Hodgkin’s Lymphoma Patients

Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.

Central Nervous System Relapse in Acute Lymphoblastic Leukemia: Incidence and Prognostic Factors